Biotts
Startup
BIOTTS S.A. is a Polish biotechnology company that develops proprietary drug technologies and drug formulations in the fields of oncology, diabetology and dermatology. Based on unique manufacturing technologies and new approach to substance combining processes and knowledge - a team of Biotts scientists has developed a breakthrough technology of universal transdermal therapeutic system MTC-Y (Multifunctional Transdermal Carrier-Y).
The properties of the carrier increase the bioavailability of active substances several times, enabling them to penetrate through the skin into soft tissues and bones. The carrier can be easily modified to obtain targeted action in pathologically changed tissues. Thanks to the system, it is possible to reduce the therapeutic dose of the drug, while maintaining its original effect and simultaneously reducing the side effects. In addition, the system enables transport of one to several active substances, which makes it possible to design multi-component drugs.
The properties of the carrier increase the bioavailability of active substances several times, enabling them to penetrate through the skin into soft tissues and bones. The carrier can be easily modified to obtain targeted action in pathologically changed tissues. Thanks to the system, it is possible to reduce the therapeutic dose of the drug, while maintaining its original effect and simultaneously reducing the side effects. In addition, the system enables transport of one to several active substances, which makes it possible to design multi-component drugs.
Get involved with Advanced Therapies Congress
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events